Pharma Giant Cipla Explores Billion-Dollar Stake Sale To Blackstone, Baring Asia: Report

Promoters of pharmaceutical major Cipla are reportedly in discussions with major private equity (PE) firms to sell a portion of their total stake in the company, Moneycontrol reported.

The move is seen as a step towards succession planning for the company.

What Happened? PE firms such as Blackstone and Baring Asia are among those in talks to explore a deal. The promoters currently own a 33.47% stake in Cipla. With Cipla’s market capitalisation exceeding $10 billion, a 25% stake sale would require a substantial investment of over $2.5 billion.

Given the age of the second-generation promoters, YK Hamied and MK Hamied, and with Samina Hamied being the only member from the second generation leading Cipla, the company is in need of a clear succession plan.

Price Action: Cipla’s share price was trading 11.19% higher at ₹1,188.10 in afternoon trade on Thursday

Read Next: Exclusive: This Architect-Turned-Entrepreneur Wants To Help You Escape Into Nature In A Tiny Home

Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

You have successfully subscribed.
Posted In: EquitiesNewsHealth CareAsset SalesMarketsGeneralBaring AsiablackstoneCipla